^Kim MA, Yun H, Kwak H, Kim J, Lee J. Design, chemical synthesis, and biological evaluation of novel triazolyl analogues of taranabant (MK-0364), a cannabinoid-1 receptor inverse agonist. Tetrahedron. 2008, 64 (48): 10802–10809. doi:10.1016/j.tet.2008.09.057.
^Woods SC. The endocannabinoid system: novel pathway for cardiometabolic Risk-factor reduction. Journal of the American Academy of Physician Assistants. November 2007,. Suppl Endocannabinoid (11): 7–10. PMID 18047036. S2CID 25472128. doi:10.1097/01720610-200711000-00005.